MIT Researchers Use Genome Editing to Seek Genes that Protect Against Parkinson’s – Parkinson’s News Today
Parkinson’s News Today |
MIT Researchers Use Genome Editing to Seek Genes that Protect Against Parkinson’s
Parkinson’s News Today Then, they applied the modified version of CRISPR in yeast cells overproducing alpha-synuclein, a protein found in Parkinson’s disease (PD) patients’ brains. In theory, this technique allows scientists to identify genes that protect cells from the PD … |
Parkinson’s News Today |
MIT Researchers Use Genome Editing to Seek Genes that Protect Against Parkinson’s
Parkinson’s News Today Then, they applied the modified version of CRISPR in yeast cells overproducing alpha-synuclein, a protein found in Parkinson’s disease (PD) patients’ brains. In theory, this technique allows scientists to identify genes that protect cells from the PD … |
Times & Star |
‘Suicide molecule’ could lead to fail-safe cancer therapy, scientists say
Times & Star Immunotherapy treatment had been partially successful because it is geared towards activating one of nature’s anti-cancer mechanisms, said Prof Peter. However, few cancers responded to immunotherapy and only a few patients benefited. He added: “Our … |
|
California moves against unlicensed stem–cell treatments — but is it doing enough?
Los Angeles Times Unlicensed stem–cell treatments aren’t innocuous — some have resulted in permanent injury to customers. Among other cases, three elderly women were reported this year to have lost all or part of their vision after a “stem–cell” solution was injected … |
|
California moves against unlicensed stem–cell treatments — but is it doing enough?
Los Angeles Times Unlicensed stem–cell treatments aren’t innocuous — some have resulted in permanent injury to customers. Among other cases, three elderly women were reported this year to have lost all or part of their vision after a “stem–cell” solution was injected … |
|
CAR-T immunotherapy now approved for certain adult lymphoma patients
Medical Xpress The Food and Drug Administration (FDA) has approved a breakthrough cancer therapy known as CAR-T for use in adults with advanced lymphoma. The therapy uses a patient’s own white blood cells, which are modified in a lab and re-trained to recognize … |